Valeant Pharmaceuticals International to Pay Anacor Pharmaceuticals, Inc. $100 Million in Breach of Contract Dispute

Published: Oct 18, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shares of Anacor Pharmaceuticals climbed Friday after the company said an arbitrator is awarding the company $100 million in a dispute with Canadian drugmaker Valeant Pharmaceuticals. The companies said Valeant was ordered to pay $100 million in damages and will also have to pay costs and attorney's fees. Anacor said it expects the award to be confirmed by the end of the year, and after that Valeant will have up to six months to pay.

Help employers find you! Check out all the jobs and post your resume.

Back to news